evenfolioETF Details
Invesco·Health·PJP · NYSE Arca
Invesco Pharmaceuticals ETF (PJP)
- Price
- $130.54
- —30 Oct 2026
- Assets
- $557.2M
- Total net assets
- Expense ratio
- 0.58%
- Category 1.00%
- Yield
- 0.92%
- Trailing distributions
- 1Y return
- 38.0%+9.2%
- Category 28.8%
- 3Y CAGR
- 25.1%+3.6%
- Category 21.5%
- 5Y CAGR
- 11.7%+7.6%
- Category 4.1%
Loading NAV history…
Invesco Pharmaceuticals ETF
Calendar-year returns
Fund only: no comparison series covers this fund's history.
Risk statistics
Five years of daily closes. Risk-free rate 4% a year.
- Standard deviation
- —
- Maximum drawdown
- —
- Sharpe ratio
- —
- Sortino ratio
- —
- Beta
- —
- Alpha
- —
- R²
- —
- Information ratio
- —
- Upside capture
- —
- Downside capture
- —
- Tracking error
- —
| Period | 1M | 3M | 6M | YTD | 1Y | 3YCAGR | 5YCAGR | 10YCAGR | LaunchCAGR |
|---|---|---|---|---|---|---|---|---|---|
| ETF | +5.9% | +7.8% | +24.6% | +25.9% | +38.0% | +25.1% | +11.7% | +9.7% | +12.0% |
| Health average | 3.6% | 9.9% | 23.0% | 20.4% | 28.8% | 21.5% | 4.1% | 10.8% | 11.6% |
| Difference | +2.3% | -2.2% | +1.6% | +5.4% | +9.2% | +3.6% | +7.6% | -1.2% | +0.4% |
Holdings
The 10 largest positions make up 50.0% of the fund.
Top holdings
| Ticker | Holding | Weight |
|---|---|---|
| GILD | Gilead Sciences Inc | 5.64% |
| PFE | Pfizer Inc | 5.62% |
| ABBV | AbbVie Inc | 5.54% |
| JNJ | Johnson & Johnson | 5.45% |
| AMGN | Amgen Inc | 5.35% |
| LLY | Eli Lilly and Co | 5.27% |
| MRK | Merck & Co Inc | 5.23% |
| ABT | Abbott Laboratories | 4.78% |
| AMRX | Amneal Pharmaceuticals Inc Ordinary Shares - Class A | 3.60% |
| LGND | Ligand Pharmaceuticals Inc | 3.56% |
Portfolio valuation
Weighted averages of what the fund holds.
- P/E
- 22.1
- P/B
- 3.2
- P/S
- 3.1
- P/CF
- 13.2
Sector allocation
Share of the equity the fund holds.
- Health care100.0%
Asset mix
- Stocks99.9%
- Cash0.1%
ETF details
- Issuer
- Invesco
- Category
- Equity · Health
- Ticker
- PJP
- Exchange
- NYSE Arca
- Inception
- 23 Jun 2005 (21.4 years)
- Structure
- Exchange Traded Fund
- Expense ratio
- 0.58% (category 1.00%)
- Holdings turnover
- 36% (category 51%)
- Distribution yield
- 0.92%
- Beta, 3 years
- 0.42
- Total net assets
- $557.2M
Prices and returns as of 30 Oct 2026; total return with distributions reinvested, before brokerage and taxes. Not investment advice.
Other health ETFs
Other ETFs in the Health category.
- XPH · State Street SPDR S&P Pharmaceuticals ETFState Street Investment Management · $524M · ER 0.35%5Y 7.5%
- BBH · VanEck Biotech ETFVanEck · $487.7M · ER 0.35%5Y 5.8%
- PBE · Invesco Biotechnology & Genome ETFInvesco · $423.5M · ER 0.59%5Y 6.9%
- PTH · Invesco Dorsey Wright Healthcare Momentum ETFInvesco · $367M · ER 0.60%5Y 2.5%
- PINK · Simplify Health Care ETFSimplify Asset Management · $349M · ER 0.51%5Y 9.7%
- IDNA · iShares Genomics Immunology and Healthcare ETFiShares · $299M · ER 0.47%5Y -2.0%